Chairman Michael J. Farrell - 23 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
23 Nov 2022
Net transactions value
-$7,458,832
Form type
4
Filing time
23 Nov 2022, 17:32:37 UTC
Previous filing
18 Nov 2022
Next filing
16 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +56,115 +14% $0.000000 470,139 23 Nov 2022 Direct F1
transaction RMD ResMed Common Stock Tax liability $7,458,832 -33,239 -7.1% $224.40 436,900 23 Nov 2022 Direct F2
holding RMD ResMed Common Stock 4,090 23 Nov 2022 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.
F2 Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.